<DOC>
	<DOCNO>NCT00006377</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining one drug may kill tumor cell . PURPOSE : Phase II trial study effectiveness combine doxorubicin , paclitaxel , carboplatin treat patient primary stage III , stage IV , recurrent endometrial cancer .</brief_summary>
	<brief_title>Doxorubicin , Paclitaxel , Carboplatin Treating Patients With Primary Stage III , Stage IV , Recurrent Endometrial Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Determine response rate duration response patient primary stage III IV recurrent endometrial cancer treat sequential doxorubicin , paclitaxel , carboplatin . OUTLINE : Patients receive sequential chemotherapy comprise doxorubicin IV every 2 week 3 course , follow paclitaxel IV 1 hour weekly 9 course , carboplatin IV every 3 week 3 course absence disease progression unacceptable toxicity . PROJECTED ACCRUAL : A total 18-46 patient accrue study .</detailed_description>
	<mesh_term>Endometrial Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Liposomal doxorubicin</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically prove primary stage III IV recurrent endometrial cancer Bidimensionally measurable disease xray , CT scan , MRI scan , physical exam Sole site may within previously irradiate area document disease progression since prior radiotherapy PATIENT CHARACTERISTICS : Age : Adult Performance status : Karnofsky 70100 % Life expectancy : At least 12 week Hematopoietic : Absolute neutrophil count great 1,000/mm^3 Platelet count least 100,000/mm^3 Hepatic : Bilirubin , SGOT , alkaline phosphatase great 1.5 time normal Renal : Creatinine great 1.8 mg/dL Cardiovascular : Left ventricular ejection fraction least 50 % Other : No active uncontrolled infection No great grade II neuropathy No active malignancy Not pregnant Negative pregnancy test Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : No prior doxorubicin Greater 6 month since prior paclitaxel , carboplatin , platinum compound Endocrine therapy : Not specify Radiotherapy : See Disease Characteristics At least 4 week since prior radiotherapy recover Surgery : Not specify</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>stage III endometrial carcinoma</keyword>
	<keyword>stage IV endometrial carcinoma</keyword>
	<keyword>recurrent endometrial carcinoma</keyword>
</DOC>